Skip to main content
. 2021 Oct 18;135(1):52–62. doi: 10.1097/CM9.0000000000001768

Table 1.

Baseline characteristics according to discharge heart rate groups.

Characteristics <65 bpm (n = 215) 65–85 bpm (n = 1256) ≥86 bpm (n = 289) Statistics P value
Demographic factors
 Age (years) 70 (62, 76) 69 (61, 77) 67 (57, 75) 9.588 0.008
 Female 79 (36.7) 535 (42.6) 109 (37.7) 4.233 0.122
Current smoking 43 (20.0) 260 (20.7) 74 (25.6) 3.599 0.161
Medical history
 Implantation of pacemaker 22 (10.2) 67 (5.3) 4 (1.4) 19.327 <0.001
 Coronary artery disease 117 (54.4) 652 (51.9) 143 (49.5) 1.212 0.544
 Myocardial infarction 39 (18.1) 153 (12.2) 35 (12.1) 6.029 0.050
 Non-ischemic cardiomyopathy 52 (24.1) 229 (18.2) 62 (21.5) 4.892 0.082
 Stroke 52 (24.2) 313 (24.9) 54 (18.7) 5.000 0.080
 Hypertension 127 (59.1) 716 (57.0) 127 (43.9) 17.733 <0.001
 LDL-C election 18 (8.4) 152 (12.1) 33 (11.4) 2.699 0.270
 Diabetes mellitus 70 (32.6) 351 (27.9) 77 (26.6) 2.339 0.303
 Reduced renal function 78 (36.2) 333 (26.5) 67 (23.1) 11.295 0.004
 Valvular heart disease 55 (25.6) 316 (25.2) 69 (23.9) 0.278 0.882
 COPD 43 (20.0) 254 (20.2) 48 (16.6) 1.942 0.373
LVEF (%) 47.0 (36.0, 57.0) 49.0 (38.7, 59.0) 46.0 (35.0, 56.0) 9.967 0.007
 <50% 118 (54.9) 651 (51.8) 165 (57.1) 4.393 0.230
Electrocardiographic results
 QRS duration (ms) 108 (94, 124) 99 (90, 114) 99 (88, 114) 17.900 <0.001
 Left bundle branch block 14 (6.5) 58 (4.6) 9 (3.1) 3.247 0.198
 Right bundle branch block 23 (10.7) 131 (10.4) 33 (11.4) 0.252 0.886
 Atrioventricular block (II–III) 17 (7.9) 19 (1.5) 3 (1.0) 36.919 <0.001
 Atrial tachycardia 22 (10.2) 58 (4.6) 5 (1.7) 19.848 <0.001
 Ventricular tachycardia 27 (12.6) 105 (8.4) 14 (4.8) 9.633 0.008
Laboratory tests
 Serum sodium (mmol/L) 139.3 (137.0, 142.0) 139.7 (137.0, 142.0) 139.1 (137.0, 142.0) 0.941 0.643
 Serum potassium (mmol/L) 4.2 (3.9, 4.6) 4.1 (3.8, 4.5) 4.1 (3.8, 4.5) 5.421 0.067
 Troponin T (ng/L) 23.1 (15.0, 42.8) 18.3 (11.6, 30.4) 19.6 (11.8, 38.5) 20.983 <0.001
 Creatinine (μmol/L) 99.0 (83.0, 119.3) 92.2 (77.7, 107.7) 94.2 (79.6, 107.6) 15.122 <0.001
 NT-proBNP (pg/mL) 1809.0 (738.0, 3354.0) 1399.0 (693.1, 3008.0) 1850.0 (826.2, 3552.0) 8.893 0.012
NYHA classifications (III–IV) 180 (83.7) 985 (78.4) 244 (84.4) 5.528 0.061
SBP at discharge (mmHg) 120 (108, 130) 120 (110, 130) 120 (110, 130) 5.439 0.063
DBP at discharge (mmHg) 70 (60, 75) 70 (67, 80) 72 (67, 80) 32.231 <0.001
Heart rhythm at discharge (AF) 135 (62.8) 961 (76.5) 249 (86.2) 46.269 <0.001
Rhythm control in hospital
 Antiarrhythmic agents∗ 45 (21.0) 110 (8.8) 18 (6.0) 35.406 <0.001
 Radiofrequency ablation for AF 2 (1.0) 6 (1.0) 3 (1.0) 1.562 0.460
Persistent/permanent (vs. paroxysmal) AF 123 (57.2) 895 (71.3) 219 (75.8) 44.687 <0.001
Medications at discharge
 Beta-blockers 104 (48.4) 765 (60.9) 171 (59.2) 11.903 0.003
 ACEI/ARB 106 (49.3) 642 (51.1) 113 (39.1) 13.585 0.001
 Aldosterone antagonists 132 (61.4) 806 (64.2) 190 (65.7) 1.023 0.599
 Diuretic 150 (69.8) 878 (69.9) 205 (70.9) 0.135 0.938
 Digoxin 60 (28.0) 392 (31.2) 124 (42.9) 17.282 <0.001
 Antiarrhythmic agents∗ 25 (12.0) 44 (4.0) 10 (4.0) 29.187 <0.001
Length of stay in hospital 11 (8, 14) 10 (7, 13) 9 (7, 12) 16.648 <0.001

Data are median (IQR) or n (%). The differences of quantitative indexes or categorical variables between the three groups were analyzed using Kruskal-Wallis test or χ2 test. ∗Antiarrhythmic agents including amiodarone, sotalol, and propafenone. ACEI: Angiotensin-converting enzyme inhibitor; AF: Atrial fibrillation; ARB: Angiotensin receptor blocker; Bpm: Beats per minute; COPD: Chronic obstructive pulmonary disease; DBP: Diastolic blood pressure; IQR: Interquartile range; LDL-C: Low-density lipoprotein cholesterol; LVEF: Left ventricular ejection fraction; NT-proBNP: N-terminal pro-brain natriuretic peptide; NYHA: New York Heart Association; SBP: Systolic blood pressure.